<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33692125</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>S-nitrosylated TDP-43 triggers aggregation, cell-to-cell spread, and neurotoxicity in hiPSCs and in vivo models of ALS/FTD.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2021368118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2021368118</ELocationID><Abstract><AbstractText>Rare genetic mutations result in aggregation and spreading of cognate proteins in neurodegenerative disorders; however, in the absence of mutation (i.e., in the vast majority of "sporadic" cases), mechanisms for protein misfolding/aggregation remain largely unknown. Here, we show environmentally induced nitrosative stress triggers protein aggregation and cell-to-cell spread. In patient brains with amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD), aggregation of the RNA-binding protein TDP-43 constitutes a major component of aberrant cytoplasmic inclusions. We identify a pathological signaling cascade whereby reactive nitrogen species cause S-nitrosylation of TDP-43 (forming SNO-TDP-43) to facilitate disulfide linkage and consequent TDP-43 aggregation. Similar pathological SNO-TDP-43 levels occur in postmortem human FTD/ALS brains and in cell-based models, including human-induced pluripotent stem cell (hiPSC)-derived neurons. Aggregated TDP-43 triggers additional nitrosative stress, representing positive feed forward leading to further SNO-TDP-43 formation and disulfide-linked oligomerization/aggregation. Critically, we show that these redox reactions facilitate cell spreading in vivo and interfere with the TDP-43 RNA-binding activity, affecting SNMT1 and phospho-(p)CREB levels, thus contributing to neuronal damage in ALS/FTD disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pirie</LastName><ForeName>Elaine</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine and Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA 92093.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Chang-Ki</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-6075-6000</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cieplak</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0700-5691</Identifier><AffiliationInfo><Affiliation>Bioinformatics and Structural Biology Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Henry R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deal</LastName><ForeName>Amanda K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghatak</LastName><ForeName>Swagata</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Fernando J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine and Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA 92093.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Gene W</ForeName><Initials>GW</Initials><Identifier Source="ORCID">0000-0002-0799-6037</Identifier><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine and Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA 92093.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yates</LastName><ForeName>John R</ForeName><Initials>JR</Initials><Suffix>3rd</Suffix><Identifier Source="ORCID">0000-0001-5267-1672</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Tomohiro</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-4246-7771</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037; tnakamura@scripps.edu slipton@scripps.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipton</LastName><ForeName>Stuart A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037; tnakamura@scripps.edu slipton@scripps.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Translational Center, The Scripps Research Institute, La Jolla, CA 92037.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, University of California San Diego School of Medicine, La Jolla, CA 92093.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P41 GM103533</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG061845</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG065372</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG056259</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS086890</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG004659</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP1 DA041722</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS103172</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA048882</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057409</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026361">Reactive Nitrogen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026403">S-Nitrosothiols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI="D003545">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003545" MajorTopicYN="N">Cysteine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066263" MajorTopicYN="N">Protein Aggregation, Pathological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012323" MajorTopicYN="N">RNA Processing, Post-Transcriptional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026361" MajorTopicYN="N">Reactive Nitrogen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026403" MajorTopicYN="N">S-Nitrosothiols</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">S-nitrosylation</Keyword><Keyword MajorTopicYN="N">TDP-43 proteinopathy</Keyword><Keyword MajorTopicYN="N">aggregation</Keyword><Keyword MajorTopicYN="N">spread</Keyword></KeywordList><CoiStatement>Competing interest statement: G.W.Y. is a cofounder of Locana and Eclipse Bioinnovations and a member of the scientific advisory boards of Locana, Eclipse Bioinnovations, and Aquinnah Pharmaceuticals. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. S.A.L. is a scientific cofounder of Adamas Pharmaceuticals, Inc. and EuMentis Therapeutics, Inc., as disclosed to the institutions with which he is academically affiliated and performs research in accordance with their conflict of interest policies.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33692125</ArticleId><ArticleId IdType="pmc">PMC7980404</ArticleId><ArticleId IdType="doi">10.1073/pnas.2021368118</ArticleId><ArticleId IdType="pii">2021368118</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gao F. B., Almeida S., Lopez-Gonzalez R., Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 36, 2931&#x2013;2950 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., et al. ., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130&#x2013;133 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S. C., Polymenidou M., Cleveland D. W., Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron 79, 416&#x2013;438 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton M. J., et al. ., Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302&#x2013;13309 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Huntley M. L., Perry G., Wang X., Pathomechanisms of TDP-43 in neurodegeneration. J. Neurochem., 10.1111/jnc.14327 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14327</ArticleId><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C. M., et al. ., TDP-43 aggregation in neurodegeneration: Are stress granules the key? Brain Res. 1462, 16&#x2013;25 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., et al. ., Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60&#x2013;70 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Moujalled D., et al. ., Kinase inhibitor screening identifies cyclin-dependent Kinases and glycogen synthase kinase 3 as potential modulators of TDP-43 cytosolic accumulation during cell stress. PLoS One 8, e67433 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3694067</ArticleId><ArticleId IdType="pubmed">23840699</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., et al. ., Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123&#x2013;133 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler M. S., et al. ., TDP-43 is intercellularly transmitted across axon terminals. J. Cell Biol. 211, 897&#x2013;911 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Lee V. M., Trojanowski J. Q., Spreading of pathology in neurodegenerative diseases: A focus on human studies. Nat. Rev. Neurosci. 16, 109&#x2013;120 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4312418</ArticleId><ArticleId IdType="pubmed">25588378</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., et al. ., Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 4, 124&#x2013;134 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J. R., et al. ., Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14, 452&#x2013;458 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., et al. ., Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency. Nature 588, 459&#x2013;465 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746606</ArticleId><ArticleId IdType="pubmed">32866962</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F., Martinez-Lage M., Kwong L. K., Lee V. M., Trojanowski J. Q., Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: The TDP-43 diseases. J. Neurol. 256, 1205&#x2013;1214 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2790321</ArticleId><ArticleId IdType="pubmed">19271105</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson B., Horton D. K., Mitsumoto H., Potential environmental factors in amyotrophic lateral sclerosis. Neurol. Clin. 33, 877&#x2013;888 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4646848</ArticleId><ArticleId IdType="pubmed">26515627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P. E. A., et al. ., Dioxins and related environmental contaminants increase TDP-43 levels. Mol. Neurodegener. 12, 35 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5420162</ArticleId><ArticleId IdType="pubmed">28476168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufir&#xed;a M., et al. ., ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog. Neurobiol. 142, 104&#x2013;129 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., et al. ., Aberrant protein S-nitrosylation in neurodegenerative diseases. Neuron 78, 596&#x2013;614 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712898</ArticleId><ArticleId IdType="pubmed">23719160</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess D. T., Matsumoto A., Kim S. O., Marshall H. E., Stamler J. S., Protein S-nitrosylation: Purview and parameters. Nat. Rev. Mol. Cell Biol. 6, 150&#x2013;166 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15688001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignarro L. J., Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30, 535&#x2013;560 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2188578</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88, 6368&#x2013;6371 (1991).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC52084</ArticleId><ArticleId IdType="pubmed">1648740</ArticleId></ArticleIdList></Reference><Reference><Citation>J. R. Lancaster, Jr, How are nitrosothiols formed de novo in vivo? Arch. Biochem. Biophys. 617, 137&#x2013;144 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27794428</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B. C., Marletta M. A., Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr. Opin. Chem. Biol. 16, 498&#x2013;506 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3518608</ArticleId><ArticleId IdType="pubmed">23127359</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., et al. ., Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer&#x2019;s disease. Science, 10.1126/science.aaw0843 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw0843</ArticleId><ArticleId IdType="pmc">PMC8091809</ArticleId><ArticleId IdType="pubmed">33273062</ArticleId></ArticleIdList></Reference><Reference><Citation>Group W.; Writing Group; Edaravone (MCI-186) ALS 19 Study Group , Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol. 16, 505&#x2013;512 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh K., Ikeda Y., Shioda S., Tobe T., Yoshikawa T., Edarabone scavenges nitric oxide. Redox Rep. 7, 219&#x2013;222 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12396667</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe T., Yuki S., Egawa M., Nishi H., Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268, 1597&#x2013;1604 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8138971</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T. J., Hwang A. W., Unger T., Trojanowski J. Q., Lee V. M., Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 31, 1241&#x2013;1252 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3297986</ArticleId><ArticleId IdType="pubmed">22193716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabdano S. O., et al. ., Onset of disorder and protein aggregation due to oxidation-induced intermolecular disulfide bonds: Case study of RRM2 domain from TDP-43. Sci. Rep. 7, 11161 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5593996</ArticleId><ArticleId IdType="pubmed">28894122</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang C. K., Chiang M. H., Toh E. K., Chang C. F., Huang T. H., Molecular mechanism of oxidation-induced TDP-43 RRM1 aggregation and loss of function. FEBS Lett. 587, 575&#x2013;582 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23384725</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamler J. S., Toone E. J., Lipton S. A., Sucher N. J., (S)NO signals: Translocation, regulation, and a consensus motif. Neuron 18, 691&#x2013;696 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9182795</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffrey S. R., Erdjument-Bromage H., Ferris C. D., Tempst P., Snyder S. H., Protein S-nitrosylation: A physiological signal for neuronal nitric oxide. Nat. Cell Biol. 3, 193&#x2013;197 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11175752</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura T., et al. ., Transnitrosylation of XIAP regulates caspase-dependent neuronal cell death. Mol. Cell 39, 184&#x2013;195 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2924818</ArticleId><ArticleId IdType="pubmed">20670888</ArticleId></ArticleIdList></Reference><Reference><Citation>Uehara T., et al. ., S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513&#x2013;517 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16724068</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H., et al. ., Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif. Neuron 53, 53&#x2013;64 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855274</ArticleId><ArticleId IdType="pubmed">17196530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei S. Z., et al. ., Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8, 1087&#x2013;1099 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1376999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolhuter K., et al. ., Evidence against stable protein S-Nitrosylation as a widespread mechanism of post-translational regulation. Mol. Cell 69, 438&#x2013;450.e5 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807093</ArticleId><ArticleId IdType="pubmed">29358077</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Kaneko K., Watanabe S., Yamanaka K., Nukina N., A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 286, 18664&#x2013;18672 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099683</ArticleId><ArticleId IdType="pubmed">21454603</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., et al. ., Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS One 5, e13250 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F., et al. ., Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 66, 180&#x2013;189 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774117</ArticleId><ArticleId IdType="pubmed">19204154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukavsky P. J., et al. ., Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 20, 1443&#x2013;1449 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24240615</ArticleId></ArticleIdList></Reference><Reference><Citation>Doulias P. T., et al. ., Structural profiling of endogenous S-nitrosocysteine residues reveals unique features that accommodate diverse mechanisms for protein S-nitrosylation. Proc. Natl. Acad. Sci. U.S.A. 107, 16958&#x2013;16963 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2947911</ArticleId><ArticleId IdType="pubmed">20837516</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel F. C., et al. ., Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J. 29, 209&#x2013;221 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2808372</ArticleId><ArticleId IdType="pubmed">19910924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S. H., Shanware N. P., Bowler M. J., Tibbetts R. S., Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 285, 34097&#x2013;34105 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2962508</ArticleId><ArticleId IdType="pubmed">20720006</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T. J., Lee V. M., Trojanowski J. Q., TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol. Med. 17, 659&#x2013;667 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202652</ArticleId><ArticleId IdType="pubmed">21783422</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan S. D., et al. ., Isogenic human iPSC Parkinson&#x2019;s model shows nitrosative stress-induced dysfunction in MEF2-PGC1&#x3b1; transcription. Cell 155, 1351&#x2013;1364 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028128</ArticleId><ArticleId IdType="pubmed">24290359</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X. T., et al. ., A&#x3b2;1-16 can aggregate and induce the production of reactive oxygen species, nitric oxide, and inflammatory cytokines. J. Alzheimers Dis. 27, 401&#x2013;413 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21860093</ArticleId></ArticleIdList></Reference><Reference><Citation>Shodai A., et al. ., Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem. 288, 14886&#x2013;14905 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3663511</ArticleId><ArticleId IdType="pubmed">23558684</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., et al. ., The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22, 869&#x2013;878 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvatori I., et al. ., Differential toxicity of TDP-43 isoforms depends on their sub-mitochondrial localization in neuronal cells. J. Neurochem., 10.1111/jnc.14465 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14465</ArticleId><ArticleId IdType="pubmed">29779213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., et al. ., Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo. Mol. Neurodegener. 12, 37 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5422931</ArticleId><ArticleId IdType="pubmed">28482850</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., et al. ., TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051&#x2013;1061 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz J., et al. ., C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol. Neurodegener. 6, 57 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3162576</ArticleId><ArticleId IdType="pubmed">21819629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J. P., Pletnikova O., Troncoso J. C., Wong P. C., TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650&#x2013;655 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M., et al. ., Cryptic exon incorporation occurs in Alzheimer&#x2019;s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. Acta Neuropathol. 133, 923&#x2013;931 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444385</ArticleId><ArticleId IdType="pubmed">28332094</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z., et al. ., Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180&#x2013;190 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim J. R., et al. ., ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167&#x2013;179 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S., et al. ., Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 9, 4220 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog J. J., et al. ., TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression. Proc. Natl. Acad. Sci. U.S.A. 117, 11760&#x2013;11769 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260973</ArticleId><ArticleId IdType="pubmed">32393629</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Perspective: Don&#x2019;t keep it in the family. Nature 550, S112 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29045374</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F. J., et al. ., Protein-RNA networks regulated by normal and ALS-associated mutant HNRNPA2B1 in the nervous system. Neuron 92, 780&#x2013;795 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5123850</ArticleId><ArticleId IdType="pubmed">27773581</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J. O.et al. .; ITALSGEN Consortium , Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857&#x2013;864 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G. D., et al. ., Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377&#x2013;381 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan J. R., Kolaitis R. M., Taylor J. P., Parker R., Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461&#x2013;1474 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3760148</ArticleId><ArticleId IdType="pubmed">23791177</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizza S., et al. ., S-nitrosylation drives cell senescence and aging in mammals by controlling mitochondrial dynamics and mitophagy. Proc. Natl. Acad. Sci. U.S.A. 115, E3388&#x2013;E3397 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899480</ArticleId><ArticleId IdType="pubmed">29581312</ArticleId></ArticleIdList></Reference><Reference><Citation>Purice M. D., Taylor J. P., Linking hnRNP function to ALS and FTD pathology. Front. Neurosci. 12, 326 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962818</ArticleId><ArticleId IdType="pubmed">29867335</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J. P., Brown R. H. Jr, Cleveland D. W., Decoding A. L. S., Decoding ALS: From genes to mechanism. Nature 539, 197&#x2013;206 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivoli-Vega M., Guri P., Chiti F., Bemporad F., Insight into the folding and dimerization mechanisms of the N-terminal domain from human TDP-43. Int. J. Mol. Sci. 21, (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7504384</ArticleId><ArticleId IdType="pubmed">32872449</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiina Y., Arima K., Tabunoki H., Satoh J., TDP-43 dimerizes in human cells in culture. Cell. Mol. Neurobiol. 30, 641&#x2013;652 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20043239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargsted L., et al. ., Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model. Sci. Rep. 7, 14266 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660202</ArticleId><ArticleId IdType="pubmed">29079747</ArticleId></ArticleIdList></Reference><Reference><Citation>Motulsky H. J., Brown R. E., Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics 7, 123 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1472692</ArticleId><ArticleId IdType="pubmed">16526949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>